Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

FGF3 from Xenopus laevis

P Kiefer1, M Mathieu, M J Close

  • 1Imperial Cancer Research Fund, London, UK.

The EMBO Journal
|November 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Physiotherapist-related barriers and enablers to the implementation of high-value physiotherapy for chronic pain: a scoping review and narrative synthesis of 37 studies.

Disability and rehabilitation·2026
Same author

Community outbreak of invasive group A streptococcus infection in Ontario, Canada.

Canada communicable disease report = Releve des maladies transmissibles au Canada·2019
Same author

Treatment of hepatitis C with 8 weeks of ledipasvir/sofosbuvir: Highly effective in a predominantly black male patient population.

Journal of viral hepatitis·2017
Same author

Elevating glucose and insulin secretion by carbohydrate formulation diets in late lactation to improve post-weaning fertility in primiparous sows.

Reproduction in domestic animals = Zuchthygiene·2016
Same author

Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study.

Annals of the rheumatic diseases·2015
Same author

An overview of the prison population and the general health status of prisoners.

British dental journal·2014
Same journal

Chromosome condensation mechanically primes the nucleus for mitosis.

The EMBO journal·2026
Same journal

NDR kinase SAX-1 controls dendrite branch-specific elimination during neuronal remodeling in C. elegans.

The EMBO journal·2026
Same journal

Assembly of the catalytic module and the rotor of human ATP synthase.

The EMBO journal·2026
Same journal

Substrate-induced assembly and functional mechanism of the membrane protein insertase SecYEG-YidC.

The EMBO journal·2026
Same journal

Conformational changes of the baseplate regulating tail contraction of Staphylococcus phage 812.

The EMBO journal·2026
Same journal

Cellular assembly and functional resilience of the mammalian RNA exosome.

The EMBO journal·2026
See all related articles

Fibroblast growth factor 3 (FGF3) in Xenopus laevis (XFGF3) is secreted and binds to cell surfaces. It transforms cell morphology and stimulates DNA synthesis, with variations based on FGF receptor interactions.

Area of Science:

  • Developmental Biology
  • Molecular Biology
  • Cell Biology

Background:

  • Fibroblast growth factor 3 (FGF3) initially identified as a mouse mammary tumor virus oncogene product.
  • Normal FGF3 function is primarily observed during embryonic development.

Purpose of the Study:

  • Investigate the function of FGF3 in Xenopus laevis by isolating and characterizing its homologue, XFGF3.
  • Understand the biochemical properties and biological activities of XFGF3.

Main Methods:

  • Isolation and expression of XFGF3 cDNA in COS-1 cells.
  • Characterization of XFGF3 protein products (p31 and p27) including secretion, cell surface association, and glycosylation.
  • Analysis of XFGF3 binding to heparin-Sepharose and displacement by soluble heparin.

Related Experiment Videos

  • Assessment of XFGF3's ability to induce morphological transformation and DNA synthesis in various cell lines expressing FGF receptors.
  • Construction and analysis of XFGF3-mouse FGF3 chimeras.

    • Main Results:

    • XFGF3 cDNA expression yields a secreted, cell surface-associated 31 kDa protein (p31) and a truncated 27 kDa form (p27), both glycosylated.
    • Both XFGF3 forms bind heparin and can be displaced by soluble heparin.
    • Conditioned medium with XFGF3 induces morphological transformation in NIH3T3 cells and stimulates DNA synthesis in quiescent C57MG and BALB/MK cells.
    • Chimeric FGF3 proteins showed altered host range dependent on the proportion of mouse FGF3 sequences.

    Conclusions:

    • XFGF3 exhibits distinct biochemical and functional properties compared to its mouse counterpart.
    • XFGF3 plays a role in cell signaling, influencing cell morphology and proliferation through interactions with FGF receptors.
    • Structural modifications, particularly involving the N-terminus, influence the specificity of FGF3 activity.